Dashboard
Manage Tickers

LLYELI LILLY & Co

NYSE lilly.com


$ 879.07 $ -4.88 (-0.55 %)    

Friday, 14-Jun-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 878.45
$ 881.62
$ 0.00 x 0
$ 0.00 x 0
$ 876.48 - $ 884.12
$ 431.12 - $ 885.06
2,023,264
na
793.94B
$ 0.57
$ 129.34
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-17-2021 12-31-2020 10-K
15 10-28-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-19-2020 12-31-2019 10-K
19 10-25-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 07-25-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-K
27 10-27-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 05-01-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-19-2015 12-31-2014 10-K
39 10-29-2014 09-30-2014 10-Q
40 07-28-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

analyzing-eli-lilly-and-co-in-comparison-to-competitors-in-pharmaceuticals-industry
Analyzing Eli Lilly and Co In Comparison T...
06/14/2024 15:00:14

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
06/13/2024 17:35:22

jpmorgans-500m-venture-capital-fund-bets-big-on-weight-loss-drugs-theyre-all-the-rage
JPMorgan's $500M Venture Capital Fund Bets...
06/13/2024 13:26:51

JPMorgan's $500M venture capital fund dives into weight-loss craze, eyeing potential market upheaval in pharmaceuticals.

eli-lilly-and-co-stock-a-deep-dive-into-analyst-perspectives-17-ratings
Eli Lilly and Co Stock: A Deep Dive Into A...
06/12/2024 21:00:18

fda-grants-traditional-approval-to-selpercatinib-for-advanced-ret-fusion-positive-thyroid-cancer-in-patients-2-and-older-previously-received-accelerated-approval-for-patients-12-and-older-in-2020
FDA Grants Traditional Approval To Selperc...
06/12/2024 18:18:25

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-selpercatinib-ret-fusion-positive-thyroid-cancer

cantor-fitzgerald-reiterates-overweight-on-eli-lilly-and-co-maintains-885-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/12/2024 16:05:03

Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly and Co (NYSE:LLY) with a Overweight and maintains $885 price target.

humans-clamor-for-weight-loss-drugs-but-the-next-users-could-be-pets
Humans Clamor For Weight Loss Drugs, But T...
06/12/2024 15:42:25

Could GLP-1 drugs for weight loss in pets be the next big thing? Success of Novo Nordisk and Eli Lilly in human market could pa...

Core News & Articles
Biogen Exec Says The Alzheimer's Drug Mark...
06/12/2024 15:30:20

- Goldman Sachs Conference

Core News & Articles
Biogen Exec Says LEQEMBI Is Going To Do V...
06/12/2024 15:28:03

- Goldman Sachs Conference

jim-cramer-sees-eli-lilly-as-more-than-a-one-trick-pony-after-fda-advisors-back-its-alzheimers-drug-its-ultimately-headed-to-a-trillion-dollar-valuation
Jim Cramer Sees Eli Lilly As More Than A '...
06/12/2024 03:52:10

Jim Cramer has expressed his confidence in Eli Lilly and Co, citing the company's diverse drug portfolio and the recent end...

eli-lillys-donanemab-gains-favorable-fda-advisory-verdict-boosting-stock-potential-says-bofa-analyst
Eli Lilly's Donanemab Gains Favorable FDA ...
06/11/2024 18:19:10

Eli Lilly's donanemab for Alzheimer's disease garners positive FDA committee verdict, prompting analyst's bullish o...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
06/11/2024 17:35:23

cantor-fitzgerald-reiterates-overweight-on-eli-lilly-and-co-maintains-885-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/11/2024 16:27:43

Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly and Co (NYSE:LLY) with a Overweight and maintains $885 price target.

Core News & Articles
'Google's Verily to offer GLP-1 drugs thro...
06/11/2024 16:08:09

https://www.statnews.com/2024/06/11/google-verily-glp1-weight-loss-drugs-lightpath-onduo/

top-4-health-care-stocks-that-may-keep-you-up-at-night-this-month
Top 4 Health Care Stocks That May Keep You...
06/11/2024 12:44:36

why-is-eli-lilly-stock-trading-higher-premarket-tuesday
Why Is Eli Lilly Stock Trading Higher Prem...
06/11/2024 11:51:12

Shares of Eli Lilly surged as an FDA advisory committee endorsed donanemab, an Alzheimer's treatment shown to significantly...

lilly-shares-are-trading-higher-after-the-companys-alzheimers-drug-donanemab-received-a-unanimous-11-0-vote-from-the-fdas-peripheral-and-central-nervous-system-drugs-advisory-committee
Lilly shares are trading higher after the ...
06/11/2024 11:04:44

apple-meta-celsius-eli-lilly-tesla-why-these-5-stocks-are-on-investors-radars-today
Apple, Meta, Celsius, Eli Lilly, Tesla: Wh...
06/11/2024 01:35:20

On Monday, major U.S. indices closed positively, with the Dow Jones Industrial Average rising by 0.2% to 38,868.04.

unpacking-the-latest-options-trading-trends-in-eli-lilly-and-co
Unpacking the Latest Options Trading Trend...
06/10/2024 20:01:40

lilly-alzheimers-drug-receives-unanimous-11-0-vote-from-fda-panel-fda-panel-to-review-safety-and-potential-limits-of-lilly-drug-next
Lilly Alzheimer's Drug Receives Unanimous ...
06/10/2024 19:14:42

- Bloomberg

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)